Kala Pharmaceuticals Inc. buy melinda
Start price
19.10.20
/
50%
€347.50
Target price
04.11.21
€400.00
Performance (%)
-74.04%
End price
05.11.21
€90.23
Summary
This prediction ended on 05.11.21 with a price of €90.23. The BUY prediction by melinda for Kala Pharmaceuticals Inc. performed very badly with a performance of -74.04%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Kala Pharmaceuticals Inc. | -8.461% | -8.461% | -56.641% | -97.882% |
iShares Core DAX® | -0.258% | -0.962% | 15.475% | 16.944% |
iShares Nasdaq 100 | 2.964% | 4.747% | 30.457% | 56.973% |
iShares Nikkei 225® | 1.217% | 0.285% | 5.780% | 5.634% |
iShares S&P 500 | 1.732% | 2.635% | 25.189% | 48.524% |
Comments by melinda for this prediction
In the thread Kala Pharmaceuticals diskutieren
Buy mit Kursziel 8,0
In the thread Trading Kala Pharmaceuticals
Die von melinda gewählte maximale Laufzeit wurde überschritten
Stopped prediction by melinda for Kala Pharmaceuticals Inc.
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€718.90
14.01.18
14.01.18
€856.90
16.01.18
16.01.18
8.55%
16.01.18
16.01.18
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€923.82
25.09.17
25.09.17
€1,172.6
26.12.17
26.12.17
-15.79%
26.12.17
26.12.17
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€1,024.2
25.09.17
25.09.17
€1,300.0
26.12.17
26.12.17
-15.79%
26.12.17
26.12.17
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€1,191.5
14.09.17
14.09.17
€1,307.9
25.09.17
25.09.17
-22.41%
25.09.17
25.09.17
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€1,321.0
14.09.17
14.09.17
€1,450.0
25.09.17
25.09.17
-22.41%
25.09.17
25.09.17